U.S. Markets closed

The Medicines Company to Participate in the Chardan 3rd Annual Genetic Medicines Conference

PARSIPPANY, N.J.--(BUSINESS WIRE)--

The Medicines Company (MDCO) announced that it will participate in the Chardan 3rd Annual Genetic Medicines Conference on Tuesday, October 8, 2019, in New York. The Company is scheduled to participate in a “fireside chat” discussion at 8:00 a.m. Eastern Daylight Time.

A live audio webcast will be available on The Medicines Company Investor Relations website and a replay of the presentation will be available within 48 hours of the event.

About The Medicines Company

The Medicines Company (MDCO) is a biopharmaceutical company with a singular, relentless focus on addressing the greatest global healthcare challenge and burden today – cardiovascular disease. Our purpose is to halt the deadly progression of atherosclerosis and the cardiovascular risk created by high levels of LDL-C. The Company is headquartered in Parsippany, New Jersey. For more information, please visit www.themedicinescompany.com and follow us on Twitter @MDCONews and LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20191004005333/en/